15-min delayed · Aug 25, 3:15 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering In8bio Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $6.00 to $6.00, so the covering firms are broadly aligned. The average target of $6.00 sits 411% above the current $1.18. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.35 next quarter toward $-0.96 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to In8bio Inc.
As of Aug, 1 of 1 firms rate INAB a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
INAB EPS & revenue forecast
EPS · NEXT QUARTER
$-0.35
Range $-0.65 – $-0.17 · 3 analysts · -22% YoY
Next period, 3 analysts expect In8bio Inc to earn $-0.35 a share (range $-0.65 – $-0.17), versus $-0.45 a year earlier. Full-year consensus is $-1.09, growing to $-0.96 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 3 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $829.8K next year.
Top analysts covering In8bio Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on INAB.
#1
Swayampakula Ramakanth
HC Wainwright & Co. · Rank #243
Buy
$6.00+410.6% to target
Overall win rate
38%
+ Follow
#2
SR
Soumit Roy
Jones Trading
Buy
$1.20+2.1% to target
Coverage
—
+ Follow
INAB stock forecast FAQ
What is INAB's average 12-month price target?+
The 1 analysts with a live target average $6.00 for In8bio Inc over the next 12 months, ranging from a $6.00 high to a $6.00 low.
Is INAB stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover INAB?+
1 analysts have an active rating on In8bio Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering INAB?+
Among analysts who currently cover INAB, Swayampakula Ramakanth of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #243). Their current call is Buy with a $6.00 target.
What is In8bio Inc's projected EPS for next quarter?+
The consensus estimate is $-0.35 per share (range $-0.65 – $-0.17) across 3 analysts. Full-year EPS is projected at $-1.09, rising to $-0.96 the following year.
How much revenue is In8bio Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $829.8K next year.
Have analysts been upgrading or downgrading INAB lately?+
As of Aug, 1 of 1 firms rate INAB a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their INAB calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
